arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

UTAH MEDICAL PRODUCTS INC

UTMD
$70.99 ▲ +0.70 (+1.00%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
18 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
82
Health
Excellent
Bullish
auto_awesome

Analytical Summary

UTAH MEDICAL PRODUCTS INC shows strong fundamentals with top-quartile Profit Margin (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $230.0M
Dividend Yield
Revenue Growth -5.8%
Op. Margin 29.6%
ROIC 7.6%
FCF / Share $4.42
Trailing P/E 20.4x
Price / Book 1.9x
FCF Yield 6.2%
Debt / Equity 0.00
info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$38.52M
↓ -5.8%
Net Income Profit after all expenses
$11.29M
↓ -18.7%
Operating Margin Operating profit as % of sales
29.6%
↓ -10.9% 86th
FCF / Share Free cash flow per share
$4.42
↑ +6.0%
Long-Term Debt Long-term obligations
$0.00
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
91
Returns
66
Financial Health
97
Cash Quality
75

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters